Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1131)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,366
Price
$573.48
Total Value
$783.37K
Shares Held After
41,877
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
410
Price
$572.48
Total Value
$234.72K
Shares Held After
43,243
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,215
Price
$571.64
Total Value
$694.54K
Shares Held After
43,653
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
945
Price
$570.65
Total Value
$539.26K
Shares Held After
44,868
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$569.71
Total Value
$387.40K
Shares Held After
45,813
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
269
Price
$568.21
Total Value
$152.85K
Shares Held After
46,493
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,206
Price
$567.54
Total Value
$684.45K
Shares Held After
46,762
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,347
Price
$566.56
Total Value
$763.16K
Shares Held After
47,968
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
539
Price
$565.51
Total Value
$304.81K
Shares Held After
49,315
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
159
Price
$564.35
Total Value
$89.73K
Shares Held After
49,854
% of Holdings
0.3%
Karyopharm Therapeutics Inc. (KPTI)
Rangwala Reshma — EVP & Chief Medical Officer
Shares
449
Price
$8.94
Total Value
$4.01K
Shares Held After
56,290
% of Holdings
0.8%
Onconetix, Inc. (ONCO)
HRT FINANCIAL LP — 10% Owner
Shares
49,710
Price
$0.69
Total Value
$34.30K
Shares Held After
33,649
% of Holdings
59.6%
MeiraGTx Holdings plc (MGTX)
Giroux Richard — CFO & COO
Shares
56,000
Price
$10.22
Total Value
$572.32K
Shares Held After
971,530
% of Holdings
5.4%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
30,941
Price
$14.66
Total Value
$453.60K
Shares Held After
395,146
% of Holdings
7.3%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
3,500
Price
$65.69
Total Value
$229.91K
Shares Held After
153,902
% of Holdings
2.2%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
56,368
Price
$20.06
Total Value
$1.13M
Shares Held After
1,402,200
% of Holdings
3.9%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
1,401
Price
$20.06
Total Value
$28.10K
Shares Held After
14,561
% of Holdings
8.8%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
142,604
Price
$20.06
Total Value
$2.86M
Shares Held After
5,554,904
% of Holdings
2.5%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
71,676
Price
$20.06
Total Value
$1.44M
Shares Held After
1,886,751
% of Holdings
3.7%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President & Immunovant CEO
Shares
200,000
Price
$29.59
Total Value
$5.92M
Shares Held After
1,647,546
% of Holdings
10.8%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
4,318
Price
$6.12
Total Value
$26.43K
Shares Held After
358,411
% of Holdings
1.2%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
600
Price
$1.23
Total Value
$738.00
Shares Held After
275,366
% of Holdings
0.2%
Quantum-Si Inc (QSI)
Keyes Jeffry R. — Chief Financial Officer
Shares
37,382
Price
$1.01
Total Value
$37.62K
Shares Held After
1,769,963
% of Holdings
2.1%
Quantum-Si Inc (QSI)
Hawkins Jeffrey Alan — Director
Shares
83,712
Price
$1.01
Total Value
$84.25K
Shares Held After
3,776,135
% of Holdings
2.2%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
171,963
Price
$15.77
Total Value
$2.71M
Shares Held After
2,567,245
% of Holdings
6.3%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.55
Total Value
$277.32K
Shares Held After
399,484
% of Holdings
4.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
9
Price
$168.35
Total Value
$1.52K
Shares Held After
12,666
% of Holdings
0.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
16
Price
$167.16
Total Value
$2.67K
Shares Held After
12,675
% of Holdings
0.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
3
Price
$166.91
Total Value
$500.72
Shares Held After
12,691
% of Holdings
0.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
40
Price
$165.29
Total Value
$6.61K
Shares Held After
12,694
% of Holdings
0.3%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
124
Price
$164.40
Total Value
$20.39K
Shares Held After
12,734
% of Holdings
1.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
524
Price
$163.52
Total Value
$85.68K
Shares Held After
12,858
% of Holdings
3.9%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
284
Price
$162.76
Total Value
$46.22K
Shares Held After
13,382
% of Holdings
2.1%
Protagonist Therapeutics, Inc (PTGX)
Ali Asif — Chief Financial Officer
Shares
1,750
Price
$105.47
Total Value
$184.57K
Shares Held After
59,003
% of Holdings
2.9%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
125,274
Price
$20.07
Total Value
$2.51M
Shares Held After
4,207,525
% of Holdings
2.9%
Onconetix, Inc. (ONCO)
HRT FINANCIAL LP — 10% Owner
Shares
94,462
Price
$0.75
Total Value
$70.85K
Shares Held After
83,359
% of Holdings
53.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$586.47
Total Value
$23.46K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
163
Price
$585.50
Total Value
$95.44K
Shares Held After
40,553
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
509
Price
$584.39
Total Value
$297.45K
Shares Held After
40,716
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
848
Price
$583.41
Total Value
$494.74K
Shares Held After
41,225
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,070
Price
$582.46
Total Value
$623.23K
Shares Held After
42,073
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
238
Price
$585.36
Total Value
$139.32K
Shares Held After
18,876
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
410
Price
$581.71
Total Value
$238.50K
Shares Held After
43,143
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
482
Price
$584.49
Total Value
$281.73K
Shares Held After
19,114
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,009
Price
$583.55
Total Value
$588.80K
Shares Held After
19,596
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
277
Price
$579.92
Total Value
$160.64K
Shares Held After
43,553
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
461
Price
$579.09
Total Value
$266.96K
Shares Held After
43,830
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
983
Price
$582.47
Total Value
$572.57K
Shares Held After
20,605
% of Holdings
4.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
488
Price
$581.66
Total Value
$283.85K
Shares Held After
21,588
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
165
Price
$577.94
Total Value
$95.36K
Shares Held After
44,291
% of Holdings
0.4%
Showing 151–200 of 1131 transactions (page 4 of 23)